1Furudoi A, Tanaka Shinji, Haruma Ken, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma[J].Oncology, 2002,62(2):157-166.
2Kabashima A, Maehara Y, Kakeji Y, et al. Overexpression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma[J].Oncology, 2001,60(2):146-150.
3Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer[J].Pancreas, 2001, 22(3):285-292.
4LI Qiu li, CHEN Fu jingDepartment of Head &Neck,Cancer Center,Sun Yat sen University,Guangzhou 510060,P.R.China.血管内皮生长因子-C、-D与肿瘤淋巴道转移研究进展[J].癌症,2002,21(6):696-700. 被引量：22
二级参考文献28
1Yonemura Y;Endo Y;FuJita H.Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer,1999.
2Cao Y;Linden P;Farnebo J.Vascular endothelial growth factor C induces angiogenesis in vivo[J],1998(24).
3Joukov V;Pajusola K;Kaipainen A.A novel vascular endothelial growth factor,VEGF C,is a ligand for the Flt 4(VEGFR 3) and KDR (VEGFR 2) receptor tyrosine kinases,1996(02).
4Lee J;Gray A;Yuan J.Vascular endothelial growth factor related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4[J],1996(05).
5Paavonen K;Hrelli Kuitunen N;Chilov D.Novel Human Vascular Endothelial Growth Factors Genes VEGF B and VEGF C Localize to Chromosomes 11q13 and 4q34,respectively,1996(06).
6Joukov V;Kaipainen A;Jeltsch M.Vascular Endothelial Growth Factors VEGF B and VEGF C,1997(02).
7Achen MG;Jeltsch M;Kukk E.Vascular endothelial growth factor D (VEGF D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)[J],1998(02).
9Kukk E;Lymboussaki A;Taira S.VEGF C receptor binding and pattern of expression with VEGFR 3 suggests a role in lymphatic vascular development,1996(12).
10Lymboussaki A;Olofsson B;Eriksson U.Vascular endothelial growth factor (VEGF) and VEGF C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia,1999(11).
3Loercher A, Lee TL, Ricker JL, et al. Nuclear factor - kappaB is all important modulator of the altered gene expression profile andmalignant phenotype in squamous cell carcinoma [J]. Cancer Res,2004,64(18) :6511 - 6523.
4Hall PA, Levision DA, Woods AL, et al.Proliferafing cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms [ J ]. J Pathol, 1990, 162 (4) :285 - 294.
5Yancopoulos GD, Davis S, Gale NW, et al. Vascular specific growth factors and blood vessel formation[J]. Nature,2000, 407:242 - 248.
6Evelyhe D, Patricia H, Ande V, et al. Tumor angiogensis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse mode [ J]. J Hepatol, 2003,38(6) :793 - 802.
7Haerslev T, Krag, Jacobsen G. Proliferating cell nuclear antigen(PCNA) in breast carcinoma: an study with correlation to histopathological features and prognostic factors[J]. Virchons Arch, 1994,424(1) :39 - 46.
8Niedergethmann M. High expression of vascu- lar endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas[J]. Pancreas, 2002,25(2) : 122 - 129.
9Karayiannakis AJ, Bolanaki H, Syrigos KN, et al. Serum vascular endothehal growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis[J] .Cancer Lett,2003,194(1) :119 - 124.
10Luo J. Pancreatic cancer cell derived vascular endahelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo[J]. Int J Cancer,2001,92(3) :361 - 369.
